Grail Inc (GRAL)

$50.23 -1.57 (-3.03%)
Market Cap 2.02B
Revenue (ttm) 147.17M
Net Income (ttm) -408.35M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -277.47%
Debt to Equity Ratio 0.00
Volume 992,400
Avg Vol 1,318,726
Day's Range N/A - N/A
Shares Out 38.98M
Stochastic %K 49%
Beta 5.18
Analysts Sell
Price Target $93.20

Company Profile

GRAIL, Inc., a commercial-stage healthcare company, provides multi-cancer early detection testing and services in the United States and internationally. It offers Galleri, a cancer screening test for asymptomatic individuals over 50 years of age; and DAC, a diagnostic aid for cancer tests to accelerate diagnostic resolution for patients for whom there is a clinical suspicion of cancer. The company also provides development services, including support for ongoing clinical studies, pilot testing,...

Industry: Diagnostics & Research
Sector: Healthcare
Phone: 833 694 2553
Website: grail.com
Address:
1525 O’Brien Drive, Menlo Park, United States
Coinbit
Coinbit Mar. 6 at 5:50 PM
$GRAL 48.25 today and then back to 55
0 · Reply
joshaliman
joshaliman Mar. 6 at 4:38 PM
$GRAL i need 55-58 and then i am out from this stock
0 · Reply
Chipmonk1
Chipmonk1 Mar. 5 at 4:34 PM
$GRAL is grail delisted? Seems to be nothing but 10-1 selling to 1 buyer. Anyone? Chapter 7 coming to fruition? Anyone. Hope you guys don’t lose your hard earned money. Shame. Scam artists at too
1 · Reply
OGLUCIDBULL
OGLUCIDBULL Mar. 4 at 10:42 PM
$GRAL diarhea caller
0 · Reply
Bazzzigar
Bazzzigar Mar. 4 at 6:43 PM
$GRAL NVO
0 · Reply
FuruCatcher
FuruCatcher Mar. 3 at 2:27 PM
$GRAL Looking for: BK!!!
0 · Reply
Chipmonk1
Chipmonk1 Mar. 3 at 12:32 AM
$GRAL still in business? Strange. Chapter 7 very soon
2 · Reply
ra1980
ra1980 Mar. 2 at 10:14 PM
$MDB it will do the same like $GRAL 🤔
0 · Reply
Biodude69
Biodude69 Mar. 2 at 8:18 PM
$GRAL this is shooting back over $60
0 · Reply
bubsomatic
bubsomatic Mar. 1 at 8:03 PM
$GRAL hopefully not back down. Lfg.
0 · Reply
Latest News on GRAL
Levi & Korskinsky, LLP: Grail (GRAL) Guided to 2030 Cash Runway While Key Trial Risk Went Unaddressed

Mar 5, 2026, 9:00 AM EST - 2 days ago

Levi & Korskinsky, LLP: Grail (GRAL) Guided to 2030 Cash Runway While Key Trial Risk Went Unaddressed

GRAIL Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)

Mar 2, 2026, 4:01 PM EST - 5 days ago

GRAIL Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)

GRAIL to Present at the TD Cowen 46th Annual Health Care Conference

Feb 24, 2026, 4:02 PM EST - 11 days ago

GRAIL to Present at the TD Cowen 46th Annual Health Care Conference

GRAIL Stock Tumbles — National Health Service Galleri Trial To Blame

Feb 23, 2026, 9:29 AM EST - 12 days ago

GRAIL Stock Tumbles — National Health Service Galleri Trial To Blame

'Holy Grail' Honus Wagner card sells for over $5M as family auctions it from grandfather's collection

Feb 23, 2026, 9:06 AM EST - 12 days ago

'Holy Grail' Honus Wagner card sells for over $5M as family auctions it from grandfather's collection

This once-hot cancer-detection company's stock got cut in half after a failed trial

Feb 20, 2026, 4:26 PM EST - 15 days ago

This once-hot cancer-detection company's stock got cut in half after a failed trial

Grail shares plunge after major cancer screening trial misses main goal

Feb 20, 2026, 8:35 AM EST - 15 days ago

Grail shares plunge after major cancer screening trial misses main goal

Grail Stock Plunges 50% After Earnings. But It's These Test Results That Are to Blame.

Feb 20, 2026, 4:06 AM EST - 15 days ago

Grail Stock Plunges 50% After Earnings. But It's These Test Results That Are to Blame.

Grail Shareholders Are Encouraged to Reach Out to Johnson Fistel for More Information About Potentially Recovering Their Losses

Feb 19, 2026, 9:27 PM EST - 15 days ago

Grail Shareholders Are Encouraged to Reach Out to Johnson Fistel for More Information About Potentially Recovering Their Losses

GRAIL, Inc. (GRAL) Q4 2025 Earnings Call Transcript

Feb 19, 2026, 9:25 PM EST - 15 days ago

GRAIL, Inc. (GRAL) Q4 2025 Earnings Call Transcript

GRAIL Reports Fourth Quarter and Full Year 2025 Financial Results

Feb 19, 2026, 4:02 PM EST - 16 days ago

GRAIL Reports Fourth Quarter and Full Year 2025 Financial Results

Landmark NHS-Galleri Trial Demonstrates a Substantial Reduction in Stage IV Cancer Diagnoses, Increased Stage I and II Detection of Deadly Cancers, and Four-Fold Higher Cancer Detection Rate

Feb 19, 2026, 4:01 PM EST - 16 days ago

Landmark NHS-Galleri Trial Demonstrates a Substantial Reduction in Stage IV Cancer Diagnoses, Increased Stage I and II Detection of Deadly Cancers, and Four-Fold Higher Cancer Detection Rate

GRAIL to Announce Fourth Quarter and Full Year 2025 Financial Results

Feb 16, 2026, 9:00 AM EST - 19 days ago

GRAIL to Announce Fourth Quarter and Full Year 2025 Financial Results

GRAIL Submits FDA Premarket Approval Application for the Galleri® Multi-Cancer Early Detection Test

Jan 29, 2026, 7:25 PM EST - 5 weeks ago

GRAIL Submits FDA Premarket Approval Application for the Galleri® Multi-Cancer Early Detection Test

A Study on Aging Unlocks Holy Grail of Sports Performance

Jan 26, 2026, 8:00 AM EST - 5 weeks ago

A Study on Aging Unlocks Holy Grail of Sports Performance

GRAIL Inc. - Illumina's Divested Holy Grail

Jan 20, 2026, 8:34 AM EST - 6 weeks ago

GRAIL Inc. - Illumina's Divested Holy Grail

ILMN

GRAIL, Inc. (GRAL) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript

Jan 12, 2026, 1:16 PM EST - 7 weeks ago

GRAIL, Inc. (GRAL) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript

GRAIL to Present at the 44th Annual J.P. Morgan Healthcare Conference

Dec 15, 2025, 4:01 PM EST - 2 months ago

GRAIL to Present at the 44th Annual J.P. Morgan Healthcare Conference

Deutsche Bank may have just set a holy-grail goal for the S&P 500

Nov 24, 2025, 9:11 AM EST - 3 months ago

Deutsche Bank may have just set a holy-grail goal for the S&P 500

DB IVV SPXL SPY SSO UPRO VOO

GRAIL to Present at Piper Sandler 37th Annual Healthcare Conference

Nov 18, 2025, 4:02 PM EST - 3 months ago

GRAIL to Present at Piper Sandler 37th Annual Healthcare Conference

Grail Q3 Earnings: Massive Stock Gains, Mediocre Performance - I'm Still Not Sold

Nov 13, 2025, 12:58 PM EST - 4 months ago

Grail Q3 Earnings: Massive Stock Gains, Mediocre Performance - I'm Still Not Sold

GRAIL, Inc. (GRAL) Q3 2025 Earnings Call Transcript

Nov 12, 2025, 6:21 PM EST - 4 months ago

GRAIL, Inc. (GRAL) Q3 2025 Earnings Call Transcript

GRAIL Reports Third Quarter 2025 Financial Results

Nov 12, 2025, 4:02 PM EST - 4 months ago

GRAIL Reports Third Quarter 2025 Financial Results

GRAIL to Present at 7th Annual Wolfe Research Healthcare Conference

Nov 4, 2025, 4:02 PM EST - 4 months ago

GRAIL to Present at 7th Annual Wolfe Research Healthcare Conference

Top Biotech Stocks Riding The Rally

Nov 4, 2025, 3:15 PM EST - 4 months ago

Top Biotech Stocks Riding The Rally

CTMX GRFS INCY

GRAIL to Announce Third Quarter 2025 Financial Results

Oct 29, 2025, 4:02 PM EDT - 4 months ago

GRAIL to Announce Third Quarter 2025 Financial Results

GRAIL: Buy Τhe Test That Could Redefine Cancer Screening

Oct 27, 2025, 7:00 AM EDT - 4 months ago

GRAIL: Buy Τhe Test That Could Redefine Cancer Screening

Odds of these speculative stocks making you money seems very slim, says Jim Cramer

Oct 22, 2025, 8:05 PM EDT - 4 months ago

Odds of these speculative stocks making you money seems very slim, says Jim Cramer

ASTS TGEN TMQ AUR RGTI

GRAIL, Inc. (GRAL) Discusses PATHFINDER 2 Study Results and Clinical Program in Multi-Cancer Early Detection Transcript

Oct 20, 2025, 5:05 PM EDT - 4 months ago

GRAIL, Inc. (GRAL) Discusses PATHFINDER 2 Study Results and Clinical Program in Multi-Cancer Early Detection Transcript

GRAIL, Inc. Announces $325.0 Million Private Placement Financing

Oct 20, 2025, 6:30 AM EDT - 4 months ago

GRAIL, Inc. Announces $325.0 Million Private Placement Financing

GRAIL and University of Oxford to Present Long-Term Data From the SYMPLIFY Study Evaluating the Galleri® Multi-Cancer Early Detection Test in Symptomatic Individuals at the Early Detection of Cancer Conference (EDCC)

Oct 20, 2025, 6:00 AM EDT - 4 months ago

GRAIL and University of Oxford to Present Long-Term Data From the SYMPLIFY Study Evaluating the Galleri® Multi-Cancer Early Detection Test in Symptomatic Individuals at the Early Detection of Cancer Conference (EDCC)

GRAIL PATHFINDER 2 Results Show Galleri ® Multi-Cancer Early Detection Blood Test Increased Cancer Detection More Than Seven-Fold When Added to USPSTF A and B Recommended Screenings

Oct 17, 2025, 6:08 PM EDT - 5 months ago

GRAIL PATHFINDER 2 Results Show Galleri ® Multi-Cancer Early Detection Blood Test Increased Cancer Detection More Than Seven-Fold When Added to USPSTF A and B Recommended Screenings

What's Happening With GRAIL Stock?

Oct 17, 2025, 9:55 AM EDT - 5 months ago

What's Happening With GRAIL Stock?

Samsung and GRAIL Announce Strategic Collaboration to Bring GRAIL's Galleri® Multi-Cancer Early Detection Test to Asia

Oct 16, 2025, 8:22 AM EDT - 5 months ago

Samsung and GRAIL Announce Strategic Collaboration to Bring GRAIL's Galleri® Multi-Cancer Early Detection Test to Asia

Grail: A Speculative Buy

Sep 30, 2025, 12:17 PM EDT - 5 months ago

Grail: A Speculative Buy

GRAIL to Present New Galleri® Data From More Than 32,000 Participants Across the PATHFINDER 2, SYMPLIFY and REFLECTION Studies at ESMO Congress 2025 and EDCC

Sep 23, 2025, 9:01 AM EDT - 5 months ago

GRAIL to Present New Galleri® Data From More Than 32,000 Participants Across the PATHFINDER 2, SYMPLIFY and REFLECTION Studies at ESMO Congress 2025 and EDCC

Sun World International and Pairwise Launch Strategic Partnership to Develop a Holy Grail of Produce – the Pitless Cherry

Sep 19, 2025, 8:47 AM EDT - 6 months ago

Sun World International and Pairwise Launch Strategic Partnership to Develop a Holy Grail of Produce – the Pitless Cherry

GRAIL to Present at Bernstein Insights: Healthcare Leaders and Disruptors - 2nd Annual Healthcare Forum

Sep 10, 2025, 4:02 PM EDT - 6 months ago

GRAIL to Present at Bernstein Insights: Healthcare Leaders and Disruptors - 2nd Annual Healthcare Forum

GRAIL, Inc. (GRAL) Presents At Morgan Stanley 23rd Annual Global Healthcare Conference Transcript

Sep 9, 2025, 5:31 PM EDT - 6 months ago

GRAIL, Inc. (GRAL) Presents At Morgan Stanley 23rd Annual Global Healthcare Conference Transcript

mRNA Biotechs - Long-Term Value Risks Abound

Aug 28, 2025, 6:20 AM EDT - 6 months ago

mRNA Biotechs - Long-Term Value Risks Abound

ALNY BNTX DHR ILMN IONS MRNA RGEN

GRAIL to Present at Morgan Stanley 23rd Annual Global Healthcare Conference

Aug 26, 2025, 4:02 PM EDT - 6 months ago

GRAIL to Present at Morgan Stanley 23rd Annual Global Healthcare Conference

GRAIL, Inc. (GRAL) Q2 2025 Earnings Call Transcript

Aug 12, 2025, 7:13 PM EDT - 7 months ago

GRAIL, Inc. (GRAL) Q2 2025 Earnings Call Transcript

GRAIL Reports Second Quarter 2025 Financial Results

Aug 12, 2025, 4:02 PM EDT - 7 months ago

GRAIL Reports Second Quarter 2025 Financial Results

GRAIL to Present at Canaccord Genuity 45th Annual Growth Conference

Jul 30, 2025, 4:02 PM EDT - 7 months ago

GRAIL to Present at Canaccord Genuity 45th Annual Growth Conference

GRAIL to Announce Second Quarter 2025 Financial Results

Jul 29, 2025, 4:02 PM EDT - 7 months ago

GRAIL to Announce Second Quarter 2025 Financial Results

The Holy Grail of Automation: Now a Robot Can Unload a Truck

Jun 23, 2025, 5:30 AM EDT - 9 months ago

The Holy Grail of Automation: Now a Robot Can Unload a Truck

Grail Shares Jump on Promising Results for Galleri Study

Jun 18, 2025, 12:43 PM EDT - 9 months ago

Grail Shares Jump on Promising Results for Galleri Study

Coinbit
Coinbit Mar. 6 at 5:50 PM
$GRAL 48.25 today and then back to 55
0 · Reply
joshaliman
joshaliman Mar. 6 at 4:38 PM
$GRAL i need 55-58 and then i am out from this stock
0 · Reply
Chipmonk1
Chipmonk1 Mar. 5 at 4:34 PM
$GRAL is grail delisted? Seems to be nothing but 10-1 selling to 1 buyer. Anyone? Chapter 7 coming to fruition? Anyone. Hope you guys don’t lose your hard earned money. Shame. Scam artists at too
1 · Reply
OGLUCIDBULL
OGLUCIDBULL Mar. 4 at 10:42 PM
$GRAL diarhea caller
0 · Reply
Bazzzigar
Bazzzigar Mar. 4 at 6:43 PM
$GRAL NVO
0 · Reply
FuruCatcher
FuruCatcher Mar. 3 at 2:27 PM
$GRAL Looking for: BK!!!
0 · Reply
Chipmonk1
Chipmonk1 Mar. 3 at 12:32 AM
$GRAL still in business? Strange. Chapter 7 very soon
2 · Reply
ra1980
ra1980 Mar. 2 at 10:14 PM
$MDB it will do the same like $GRAL 🤔
0 · Reply
Biodude69
Biodude69 Mar. 2 at 8:18 PM
$GRAL this is shooting back over $60
0 · Reply
bubsomatic
bubsomatic Mar. 1 at 8:03 PM
$GRAL hopefully not back down. Lfg.
0 · Reply
narahari2020
narahari2020 Mar. 1 at 6:48 PM
$GRAL what is going to be the impact of war on this stock price?
0 · Reply
JaredSotken
JaredSotken Feb. 28 at 2:51 AM
$GRAL📊
0 · Reply
CapitalGains007
CapitalGains007 Feb. 27 at 2:10 PM
$GRAL love to see the frantic attempt to reposition the NHS data as positive, despite failing. Much shakeup org wise here too Commerical verticals will need to pick up the slack but too expensive and hard to sell
0 · Reply
Bazzzigar
Bazzzigar Feb. 27 at 2:02 PM
$GRAL
0 · Reply
Bazzzigar
Bazzzigar Feb. 27 at 1:29 PM
$GRAL few more
0 · Reply
Spacerobot
Spacerobot Feb. 27 at 7:21 AM
$GRAL lte
0 · Reply
joshaliman
joshaliman Feb. 27 at 3:23 AM
$GRAL Need to enter at 49 or 50
0 · Reply
FuruCatcher
FuruCatcher Feb. 26 at 10:55 PM
$GRAL SELL THIS SCAM!!! FUCK YOU!
1 · Reply
CromieAds
CromieAds Feb. 26 at 9:42 PM
$CAI not surprised. Rocket ignited.Caris has generated over 50 billion molecular markers across more than 959,000 clinical cases, creating one of the world’s most comprehensive databases of molecular insights for cancer. it’s literally changing how cancer is understood and treated at the molecular level $GH $GRAL
0 · Reply
deeze12
deeze12 Feb. 26 at 8:42 PM
$AIDX Mentioned during the call that their technology is different from $GRAL and should have a different result.
1 · Reply
BiotechDrTrader
BiotechDrTrader Feb. 26 at 8:13 PM
$GRAL GRAL doing max pain lol - all the pre-data longs got anihilated, now all the post-data shorts getting anihilated. max pain!
0 · Reply
Woodstocks1999
Woodstocks1999 Feb. 26 at 8:00 PM
$GRAL Yep, illiterate bears thought this would be an easy short even after a 50% haircut. This is not a drug with potential side effects and it's already on the market.
1 · Reply